A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00690807
Recruitment Status : Completed
First Posted : June 5, 2008
Last Update Posted : September 28, 2009
Information provided by:
Provectus Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : September 2009